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Abstract
In the early days of gene expression data, researchers have focused on gene-level
analysis, and particularly on finding differentially expressed genes. This usually in-
volved making a simplifying assumption that genes are independent, which made
likelihood derivations feasible and allowed for relatively simple implementations. In
recent years, the scope has expanded to include pathway and ‘gene set’ analysis in
an attempt to understand the relationships between genes. We develop a method
to recover a gene network’s structure from co-expression data, measured in terms of
normalized Pearson’s correlation coefficients between gene pairs. We treat these co-
expression measurements as weights in the complete graph in which nodes correspond
to genes. To decide which edges exist in the gene network, we fit a three-component
mixture model such that the observed weights of ‘null edges’ follow a normal dis-
tribution with mean 0, and the non-null edges follow a mixture of two lognormal
distributions, one for positively- and one for negatively-correlated pairs. We show
that this so-called L2N mixture model outperforms other methods in terms of power
to detect edges, and it allows to control the false discovery rate. Importantly, the
method makes no assumptions about the true network structure.
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1 Introduction
Broadly speaking, statistical analysis of ‘omics’ data consists of studying the relative abun-
dance of biological ‘building blocks’, such as genes, proteins, and metabolites. The goal
of many studies involving high-throughput data is to identify differential building blocks
- those whose abundance levels vary according to the value of some other factor. These
factors include, for example, environmental conditions, disease state, gender, or age. To
simplify the discussion, we will use genomics terminology, where the building blocks are
genes and the abundance is their expression level. Many biological studies use statistical
methods which focus on individual genes and rely on the unrealistic, but mathematically
convenient assumption that the expression levels are independent across genes. However,
other methods drop this assumption and acknowledge that multiple genes are likely to
work as a group associated with the same biological process, thus providing not only more
complex functionality, but also robustness to detrimental mutations. A common assump-
tion is that related genes share a regulatory process, and therefore, their expression levels
are expected to be highly correlated. The relevant measurements in this context are co-
expression levels of pairs of genes, which can be measured in terms of Pearson’s correlation
coefficient, Mutual Information, Spearman’s rank correlation coefficient, or Euclidean dis-
tance. Gene co-expression data can be seen as a network; an undirected complete graph in
which nodes represent genes and weights are assigned to edges according to the strength
of the association between each pair’s expression levels, across multiple samples.
Using gene co-expression patterns, a number of authors defined ‘modules’ as sets of
genes that have similar expression patterns; they then focused on a small number of in-
tramodular ‘eigengenes’ or ‘hub genes’ instead of on thousands of genes [1, 2, 3, 4, 5].
Among them, the weighted gene co-expression network analysis (WGCNA, [2]) is a widely
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used approach. Among hub genes, the aforementioned independence assumption is more
reasonable because genes belonging to different modules are expected to be much less corre-
lated than genes within the same module. Thus, one can try to find differentially expressed
hub genes with respect to a trait or treatment. However, methods assuming a specific
structure and focusing on modules and their eigengenes or hub genes, are only suitable
for certain networks where nodes within a module are highly connected but connections
across modules are relatively rare. However, biological networks such as protein-protein
and gene-gene interaction networks may have other network features where modules cannot
be clearly partitioned. Such is the case, for example, with scale-free networks [6, 7, 8], a
scale-free regime followed by a sharp cutoff [9, 10, 11], and other networks with curved
degree distributions [12, 13, 14, 15]. Instead of identifying hub genes and comparing their
differential expression levels between two traits or treatments, there have been other ap-
proaches that compare high dimensional covariance matrices between the two groups and
identify risk genes based on the correlation structures [16, 17, 18, 19, 20]. Recently, Cai
and Liu [19] suggested a method for large-scale testing of correlations under certain reg-
ularity conditions. Zhu et al. [20] suggested a sparse leading eigenvalue driven test that
compares two high-dimensional covariance matrices obtained from schizophrenia and nor-
mal groups and identified novel schizophrenia risk genes. Such genes that are found to be
highly associated with a trait or treatment are further analyzed by using knowledge-based
pathway analysis tools such as Gene Set Enrichment Analysis (GSEA, [21, 22]). Pathway
analysis differs from co-expression analysis in that it uses pre-defined gene sets (e.g., from
the Gene Ontology (GO, [23]) or the Kyoto Encyclopedia of Genes and Genomes (KEGG,
[24]). Such analyses help determine which pathways are over- or under-represented in the
identified modules [25].
Obtaining accurate estimates of covariance (or precision) matrix is important for gene
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network analyses. However, it becomes challenging when the number of genes is larger
than the sample size (as is often the case). The problem of estimating large, sparse gene
networks has been thoroughly studied in modern multivariate analysis. Researchers have
suggested various approaches using regularization techniques, and one of most commonly
used approaches is the penalized maximum likelihood. For example, Meinshausen and
Bühlmann [26] proposed to estimate a precision matrix by imposing an l1 penalty on a
Gaussian log-likelihood to increase its sparsity. It uses a simple algorithm to estimate a
sparse precision matrix, by fitting a regression model to each variable with all other vari-
ables as predictors, and apply the lasso to obtain sparsity. Friedman et al. [27] suggested a
simple but faster algorithm called graphical lasso, which also estimates a sparse precision
matrix using coordinate descent procedure for lasso. Yuan and Lin [28], Banerjee et al.
[29], Rothman et al. [30] and Levina et al. [31] also proposed algorithms to solve the l1 pe-
nalized Gaussian log-likelihood to estimate a large, sparse precision matrix. These methods
have been extensively used to estimate sparse gene network. The use of precision matrix
for estimating gene network is justified when the data is generated from a multivariate nor-
mal distribution. Under this assumption, elements of the precision matrix correspond to
conditional independence restrictions between nodes in a gene network. These approaches
work well when analyzing gene data obtained from large retrospective studies such as the
TCGA data [32]. However, applying these approaches to datasets with a relatively small
number of samples may not yield robust estimates of the regression coefficients.
The main goal of this paper is to introduce a new method to uncover the structure of
sparse gene networks from expression data. Rather than estimating the precision matrix,
we use the covariance matrix to determine which genes are co-expressed. Sparsity in the
covariance matrix (rather than the precision matrix) is motivated mostly by biological
arguments – (i) expression level of genes are associated with their functionality, and thus,
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are expected to be highly correlated for genes that share the same functional process; and
(ii) the number of genes associated with most biological functions is small, relative to the
total number of genes. There is also a strong mathematical argument for modeling sparsity
in the covariance matrix, rather than the precision matrix. For each gene, its expression
profile is an N -dimensional vector where N is the sample size, and for each pair of genes
the correlation between their expression profiles represents the cosine of the angle between
the two corresponding vectors. So, the correlation matrix offers an intuitive representation
of the similarity between expression profiles. As Frankl and Maehara [33] showed, as N
increases, any two random vectors in the Euclidean N -dimensional space are approximately
orthogonal with probability that approaches 1. Thus, the correlation between two random
expression profiles is expected to be close to cos(pi/2) = 0, which means that the correlation
(and hence, the covariance) matrix is expected to be sparse.
While gene expression datasets consist of thousands of genes and the complete network
contains millions of edges, in most biological systems gene networks are expected to be
sparse [34]. With a finite sample, however, the observed correlations are not zero, even for
uncorrelated pairs, so the first problem is to define an accurate decision rule to differentiate
between spurious correlations and true edges. A second, related problem, is how to perform
the computation needed to implement such a rule in practice.
To address these challenges, we first obtain weights, wij, by applying Fisher’s Z trans-
formation to the sample correlation coefficients, rij. For uncorrelated pairs, the asymptotic
distribution of wij is normal, with mean zero and variance N − 3. This motivates fitting
a mixture model to {wij} in which the majority of pairs belong to a normally distributed
‘null component’, and a small percentage of the weights belong to one of two ‘non-null
components’, which follow log-normal distributions (one for positive and one for negative
correlations). This so-called L2N model was first presented in Bar and Schifano [35], in the
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context of identifying differentially expressed (or dispersed) genes. We use the L2N model
to recover a sparse gene network for the following reasons. First, the L2N mixture model
leads to shrinkage estimation and to borrowing strength across all pairs, which increases
the power to detect co-expressed pairs. Second, the specific form of the mixture model
allows us to establish a decision rule which controls the error rate. Third, the mixture
model lends itself to a computationally-efficient estimation of the parameters via the EM
algorithm [36]. Note that when Bar and Schifano [35] used the model, they assumed inde-
pendence between genes, while this is not the case in our application. Furthermore, they
used the L2N model in the k-group comparison setting, while in our application we fit the
model to detect a network for each group.
This paper is organized as follows: in Section 2 we present our method to uncover the
structure of gene networks. We discuss some computational challenges and our proposed
solutions. In Section 3 we evaluate the goodness of fit of our method and its ability
to correctly recover the network structure and compare our method’s ability to correctly
identify true edges with existing methods. In Section 4 we apply our method to a publicly
available collection of breast cancer datasets from twelve studies. We conclude with a
discussion in Section 5.
2 Statistical Model and Estimation
2.1 A Mixture Model for Edge Indicators in a Gene Network
A gene network can be represented by a weighted, undirected graph in which each node
corresponds to a gene and each edge corresponds to a pair of genes that are ‘co-expressed’,
meaning that their expression levels are highly correlated. The weights represent the
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strength of the connection between two genes, namely, their tendency to be co-expressed.
Given normalized expression data of G genes, our objective is to discover the network
structure, namely, which of the K = G(G− 1)/2 pairs are co-expressed. Our general strat-
egy is to associate with every putative edge in the complete graph with G nodes, a latent
indicator variable whose value (0 or 1) is determined by a statistical model.
To start, we define the edge weights in terms of pairwise correlation coefficients. Let
xg be a vector of normalized expression levels for gene g ∈ {1, . . . , G} obtained from N
samples (N > 3). Suppose that the true correlation coefficient between genes m and n is
ρmn, and let rmn = corr(xm,xn) be the observed correlation coefficient. Using Fisher’s Z
transformation, we obtain the estimated weight wmn = arctanh(rmn), which is known to
be approximately normally distributed, with mean arctanh(ρmn) and variance 1N−3 . Let
E = {emn} be the set of true edges in the network. We assume that G is large and that most
pairs are not co-expressed, so the network is sparse: |E|  K. This assumption, along
with asymptotic normality of wmn, motivate our model choice. Specifically, we assume
that the weights follow the so-called L2N mixture distribution in Bar and Schifano [35].
L2N is a three-component mixture model in which the ‘null’ component follows a normal
distribution with mean 0, representing the majority of pairs that have approximately zero
correlation, and the tails (the ‘non-null’ components, for pairs with strong positive/negative
correlations) follow log-normal distributions:
wmn|emn /∈ E ∼ N(0, σ2) (1)
wmn|[wmn > 0, emn ∈ E] ∼ LogNormal(θ1, κ21) , (2)
−wmn|[wmn < 0, emn ∈ E] ∼ LogNormal(θ2, κ22) . (3)
Note that σ2 consists of two variance components, namely, σ2 = 1
N−3 + σ
2
0, where
1
N−3 is
the variance component due to the asymptotic distribution of arctanh(rmn), whereas σ20
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is due to the random effect model, which allows us to account for extra variability among
uncorrelated pairs. A graphical representation of the L2N model is shown in Figure 1.
If we denote the null mixture component in the L2N model by C0, the two non-null
components by C1 and C2, the corresponding probability density functions by fj, and the
mixture probabilities by pj, for j = 0, 1, 2, such that p0 + p1 + p2 = 1, then we classify a
putative edge between nodes m and n in the complete graph into one of the three mixture
components based on the posterior probabilities,
Pr(emn ∈ Cj|wmn) = pjfj(wmn)
p0f0(wmn) + p1f1(wmn) + p2f2(wmn)
, j = 0, 1, 2. (4)
Let bmn = (b0mn, b1mn, b2mn) be an indicator vector, so that bjmn = 1 for the component
j with the highest probability, Pr(emn ∈ Cj|wmn), for the pair mn, and 0 for the other two
components. Using this notation, the G×G matrix A = [1− b0mn] denotes the adjacency
matrix between the G nodes in the graph. Our goal is to obtain an accurate estimate of
A. To do that, we treat the indicators bmn as missing data, and use the EM algorithm
[36] to estimate the parameters of the mixture model. The hierarchical and parsimonious
nature of the L2N model leads to shrinkage estimation and borrowing power across all pairs
of genes, as well as to computational efficiency. This is critical, since K is typically very
large and can be much larger than the sample size, N . Details regarding the parameter
estimation for the L2N model can be found in [35]. The algorithm is implemented as an
R-package called edgefinder (see the Supplementary Material).
2.2 Implementation Notes
There are a couple of challenges related to the parameter estimation via the EM algorithm
which should be addressed. First, the complete set of pairwise correlation coefficients,
and thus the normalized weights, wmn, cannot be assumed to be mutually independent.
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Figure 1: The L2N mixture model, with probability of the null component (blue dotted
curve), Pr(mn ∈ C0) = 0.8, where mn denotes the edge between nodes m and n in the
graph.
Conditionally, they are all asymptotically normally distributed with variance 1
N−3 , but for a
fixed m, some wmn may be correlated. Second, obtaining estimates based on all K pairwise
correlations is time-consuming and requires storing a very large matrix in the computer’s
memory, since the values of the indicator variables, bˆjmn, for each pair of genes must be
updated in each iteration of the EM algorithm.
When the number of genes is large, as is the case in the applications which motivated this
paper, we propose taking a random sample of G′ < G genes (e.g., G′ = 1000) and fitting the
mixture model to this random subset. Using the smaller subset of genes greatly improves
computational efficiency and yields highly accurate estimates. Furthermore, randomly
selecting a subset of the genes allows us to assume that the remaining weights used in the
(complete data) likelihood function are approximately independent. With the estimates
obtained from the random subset, it is then possible to compute the posterior probabilities
(4) for all K pairs, even on a computer with standard memory capacity.
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In addition to computational efficiency and increasing power through shrinkage estima-
tion, the mixture model allows us to estimate how many pairs of genes are correctly (or
incorrectly) classified as co-expressed. Specifically, for a predetermined posterior probabil-
ity ratio threshold, T > 1, we solve
c1 = arg min
w∈(0,∞)
pˆ1fˆ1(w)
pˆ0fˆ0(w)
> T and c2 = arg max
w∈(−∞,0)
pˆ2fˆ2(w)
pˆ0fˆ0(w)
> T
and set b0mn = 1 if wmn ∈ [c2, c1], and b0mn = 0 otherwise. Alternatively, for any α, we can
(numerically) find thresholds c1 > 0 and c2 < 0 such that
Pr(bˆ0mn 6= 0 | b0mn = 0) ≈ pˆ0
∫ c2
−∞
fˆ0(w)dw + pˆ0
∫ ∞
c1
fˆ0(w)dw ≤ α . (5)
That is, we control the estimated probability of a Type I error at a certain level, α. Sim-
ilarly, we can control the false discovery rate [37]. Using the thresholds c1 and c2, we can
estimate the probability of a Type II error:
Pr(bˆ0mn = 0 | b0mn 6= 0) ≈ pˆ2
∫ 0
c2
fˆ2(w)dw + pˆ1
∫ c1
0
fˆ1(w)dw. (6)
3 Simulation Study
3.1 Data Generated Under the L2N Model
In the first simulation study, we assess the power and goodness of fit of our model using
different configurations, with varying numbers of genes (G), samples (N), degrees of sparsity
(p1 + p2), and graph structures. In this section, data are generated according to the L2N
model from Section 2, and we use different parameters for the log-normal components. We
show representative results with N = 100 and G = 500 (thus, K, the maximum possible
number of edges is 124,750.) Four network configurations are used in this section. They
are described in terms of the shape of the G×G adjacency matrix, A, as follows:
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• complete: A = BlockDiag(JS − IS, 0G−S), where S = 100, J is a matrix of 1’s,
I is an identity matrix, and 0 is a matrix of zeros. This graph contains one clique
(complete subgraph) with 100 nodes, and nodes not in the clique are not connected
to other nodes. |E| = 4, 950 (≈ 0.04K), p1 = 0.0396, p2 = 0.
• ar (autoregressive): A has a Toeplitz structure, with Aij = 1/(1 + |i − j|) if both
i, j ≤ S, where S = 100. |E| = 4, 950, p1 = 0.0396, p2 = 0.
• two independent blocks: A = BlockDiag(JS − IS, JS − IS, 0G−2S), where S = 50.
(I.e., two distinct cliques, each with 50 genes.) |E| = 2, 450, p1 = 0.0196, p2 = 0.
• two negatively correlated blocks: Similar to the previous configuration, but the
two blocks are negatively correlated. |E| = 4, 950, p1 = 0.0196, p2 = 0.02.
For pairs i, j such that Aij = 0, we generated wij independently from a standard normal
distribution. In the complete and two independent blocks configurations, for Aij = 1 we
generated only positively correlated pairs (so p2 = 0), and in the two negatively correlated
blocks configuration, the pairs were positively correlated within each block, but pairs across
the two blocks were generated to be negatively correlated. For the ar structure, weights
generated from the log-normal distribution appear in the off-diagonals of A in decreasing
order. That is, the largest G − 1 weights are placed randomly in the secondary diagonal
(elements Ai,i+1), the next G−2 largest weights are placed randomly in the ternary diagonal
(elements Ai,i+2), etc. (Note that the values Aij in this case are only used to indicate that
elements along diagonals are equal, but these values are not used to generate the weights.)
All four configurations are sparse, with only 2-4% of the putative edges being present
in the graph. The two negatively correlated blocks structure has the same sparsity as the
complete and ar graphs, but it has different weights of non-null mixture components. The
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ar graph has a more constrained structure, with weights among pairs of nodes which decay
as |i − j| increases, for i, j ≤ S. Recall, however, that our method does not rely on any
assumptions about the structure of the graph. Therefore, it is expected that its performance
will only depend on the parameters involved in the mixture model. In the simulations
presented here we examined the power of the method to detect edges in the graphs as a
function of the location parameters of the log-normal components. We varied θ1, such that
θ1 ∈ {−1.25,−1,−0.75, . . . , 0.75}, and set κ21 = 0.25. In the two negatively correlated blocks
configuration, we used θ2 = θ1 and κ2 = κ1. The weights which were generated according
to the L2N model were transformed into correlation coefficients using the tanh function,
and the resulting covariance matrix was used to simulate 500 gene expression values for
100 subjects. For each configuration we generated 20 different datasets.
We applied our method and checked the goodness of fit of the mixture model and the
ability to correctly recover the structure of the network, in terms of the number of true-
and false-positive edges. In our simulations, we used the approach described in Section 2
to control the false discovery rate at the 0.01 level. To demonstrate how well our algorithm
estimates the true mixture model, we plotted for each configuration the histogram of the
observed wmn and the fitted mixture and measured the goodness of fit in terms of the root
means squared error (rMSE). In all configurations, the rMSE was very small (≤ 0.01),
and the mixture weights (p0, p1, p2) were estimated very accurately and with increasing
accuracy as θ1 increases. See, for example, Figure S1 in the supplementary material, where
the average estimate of p1 is plotted versus θ using the two negatively correlated blocks
configuration. A representative goodness of fit plot is shown in Figure 2, for the complete
configuration, with θ1 = −0.25. The red curve represents the null component, the green
lines represent the non-null components (in this case, C2 is estimated, correctly, to have a
weight which is very close to 0), and the dashed blue line is the mixture.
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Figure 2: The distribution of wmn = arctanh(rmn) for a simulated dataset with 500 genes,
of which 100 form a complete subgraph. The total number of edges in the graph is 4,950
(out of a total of 124,750 possible edges.) The red curve represents the null component,
the green curves represent the non-null components, and the dashed blue line represents
the fitted mixture distribution.
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Figure 3: The average power of our method when the data are generated according to the
L2N mixture model, as a function of θ, for a simulated dataset with 500 genes and four
different forms of adjacency matrices (complete, autoregressive, two independent blocks,
and two negatively correlated blocks). In all cases, the FDR was controlled at the 0.01
level.
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Arguably, more important than assessing goodness of fit, is determining a method’s
ability to recover the true network structure correctly, i.e. identify as many existing edges
as possible while maintaining a low number of falsely-detected edges. Figure 3 shows the
average power of our method to detect true edges for a range of values for θi (with a fixed κ2)
and for different network configurations, where power is the total number of true-positives
divided by the total number of edges in the graph. It can be seen that, as the location
parameter of the log-normal distribution increases, the power increases and approaches 1.
When the data are generated under the L2N model, this is the expected behavior, since
as θ1 (θ2) increases, the positive (negative) non-null component, C1 (C2), is pushed further
to the right (left), making it easier to discriminate between non-null and null components.
Note that our method has approximately the same power curve for all four configurations.
The average false discovery rate across all configurations and replications is 0.008. For
small values of θ1 (< −0.75), the average FDR is slightly higher (approximately 0.012) and
for θ > 0, the average FDR is less than 0.01. More detailed results regarding the achieved
false discovery rate are shown graphically in Figure S2.
3.2 Data Generated Under Other Models
In the second simulation study we evaluate the ability of our method to recover the true
network structure and compare it with other methods. For a fair comparison, the data
are not generated under L2N model. Rather, we use data generated from a multivariate
normal distribution whose covariance matrix Σ is defined as a function of an adjacency
matrix A. To generate data, we use the R-package huge [38]. We generate five types of
network configurations as follows:
• random: each edge is randomly set to exist in the graph using K i.i.d. Bernoulli(p)
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draws (p = 0.01, 0.05, 0.1). |E| ≈ 1000× (1000− 1)× p/2.
• hub: it consists of g disjoint groups, and nodes within each group are only connected
through a central node in the group (g = 25, 50, 100). |E| = 1000− g.
• band: an edge, emn between nodesm 6= n is set to exist in the graph if 1 ≤ |m−n| ≤ g
(g = 25, 50, 100). |E| = (2000− 1− g)× g/2.
• scale-free: scale-free networks are generated using the Barabási-Albert algorithm
[39]. |E| = 1, 000.
• overlapped-cluster: we modified a function that generates a cluster network that
consists of non-overlapping g groups. In the modified function, the groups are aligned
in an adjacency matrix so that each group shares 20% of the nodes with its left-
adjacent group and another 20% with its right-adjacent group. Edges in each group
are randomly generated with probability p. We use p = 0.3 for g = 25 and 50, and
p = 0.6 for g = 100. |E| ≈ (0.8× (g− 1) + 1)× (1000/g)× (1000/g− 1)× p/2. Edges
in each group are randomly generated with probability p.
For each configuration, we generated expression profiles of G = 1, 000 genes for N = 70
samples. We compare our method with three existing methods: Meinshausen-Bühlmann
graph estimation (MB, [26]), graphical lasso (glasso, [27]), and correlation thresholding
graph estimation. For each of MB and glasso, we identify edges in two different ways. First,
an edge emn between nodes m and n is estimated to exist (i.e. Aˆmn = 1) if the method
chooses the node m as a neighbor of n and the node n as a neighbor of m, which we name
as MB-AND and glasso-AND, respectively. Second, an edge emn is estimated to exist if the
method chooses the node m as a neighbor of n or the node n as a neighbor of m, which
we name as MB-OR and glasso-OR, respectively. The sparsity levels of MB and glasso
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are controlled by a regularization parameter λ and the correlation thresholding method by
setting different thresholds from 0 to three times the true sparsity level.
We compare the performance in terms of the number of true positives (i.e. correctly
identified edges) given the same total number of edges identified. We define the true
network in two different ways: (i) based on the adjacency matrix — a pair m,n is set to be
connected if and only if Amn = 1, and (ii) by applying a threshold to the true covariance
matrix — for a predetermined t, a pair is connected iff |Σmn| > t where the threshold
t is set to achieve the same sparsity level as that of the adjacency matrix. The two are
different in that the former assumes conditional independence between two nodes that not
connected by an edge, while the latter does not.
The results from the two network definitions are similar. We show the result from
(i) whose true matrix is derived from the adjacency matrix, and show the result from (ii)
whose true matrix is derived from the true covariance matrix in the supplementary material
(Figure S3).
Figure 4 depicts the numbers of true positive edges given the total number of edges
identified by each method. Our method (solid red lines) outperforms all the other methods
in random, hub, band, and overlapped-cluster networks (see Figure 4A-L). For example, in
the hub, g = 100 configuration (panel F), the true number of edges is 900 (as indicated by
the vertical line), and when our method detects 853 edges, 595 of them are true edges. In
contrast, the thresholding method yields approximately 345 true edges out of the total 856
detected; MB-OR and glasso- yield approximately 370–380 true edges out of 900–960 edges
detected; and MB-AND yields 312 true edges out of 930 edges detected. Notably, MB and
glasso are comparable to, but in some cases worse than the correlation thresholding method
in all network configurations.
The black dotted line in each plot represents the expected number of true positive edges
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Figure 4: The numbers of true positive edges given the total number of edges identified
by each method. The adjacency matrix used by the huge package is used to determine
the true edges. The y-axis represents the number of true positive edges and the x-axis
represents the total number of edges identified. The vertical line represents the number of
true edges. The black dotted line is a regression line with 0 intercept and slope equal to
the true sparsity, which represents the expected number of true positive edges when the
edges are identified in a random manner (uniformly).
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when the edges are identified in a random manner. In the band, g = 50 configuration (panel
I), the competing methods do as well as or worse than chance, whereas our method gives
much better results. In the random, p = 0.1 configuration (panel C), the other methods
perform worse than choosing edges randomly and our method performs slightly better
than chance to a certain point (approximately 30,000 total edges being detected) before
deteriorating, but still gives better results than the other methods.
The scale-free configuration appears to be especially challenging for all the methods.
They all detect only approximately 10 – 20 true edges when the total number of edges
detected was 1,000 (Figure 4M). In this case, the correlation thresholding, glasso- and
MB-OR perform only slightly better than our method.
We further explore scale-free networks with additional network sizes (G = 200, 500, 2000).
Consider that sparsity levels change as we vary the network sizes: larger G results in a more
sparse network. Figure S4 depicts the numbers of true positive edges given the total num-
ber of edges for various sizes of scale-free networks. When G = 2, 000, our method is much
better than MB-AND (as we have also seen in Figure 4M), and slightly better than the
other methods. However, when G = 200, 500, our model outperforms the other methods.
For example, when G = 200, our model identifies around 45 true edges out of 200 edges,
while glasso-, MB-OR, and the correlation thresholding methods identify less than 30 true
edges, and MB-AND identifies around 10 edges.
4 Case Study
Subtype Characterization of Breast Cancer. We analyzed a large dataset used by
Allahyar et al. [40] who introduced SyNet, a computational tool aiming to improve network-
based cancer outcome prediction. The dataset, referred to as ACES [41], contained expres-
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sion data for 12,750 genes collected from 1,616 women across 12 studies. To obtain and
preprocess the data, we used the raw data and scripts provided by Allahyar et al. [40]
via their github page (github.com/UMCUGenetics/SyNet). We focused on analyzing gene
networks by cancer subtype: Basal (n=297), Her2 Positive (n=191), Luminal A (n=584),
Luminal B (n=440), and Normal (n=104). Categorization into breast cancer types is based
on the positive/negative status of three factors: estrogen receptor (ER), progesterone re-
ceptor (PR), and the number of copies of the HER2 gene. The Basal group is called the
triple-negative breast cancer, and it includes tumors in which all three markers (ER, PR,
HER2) are negative. The Her2 group includes tumors that are ER and PR negative, but
HER2 positive. The Luminal A group includes tumors that are ER positive and PR posi-
tive, but HER2 negative. The Luminal B group includes tumors that are ER positive, PR
negative, and HER2 positive.
We selected 80 random samples from each group, and applied edgefinder to detect
the edges in the network in each of the five groups. We controlled the false discovery rate
at the 0.01 level. With 12,750 genes there are 81,274,875 possible edges in the network,
and edgefinder detects 112,071 edges in the network of the Normal group, 171,959 in the
Basal group, 144,128 in the Her2 group, 278,066 in Luminal A, and 213,200 in Luminal
B. Clearly, all five networks are very sparse (0.1-0.3% sparsity). All but two edges (in the
Basal network) belonged to the positive correlation component in the mixture model. The
results are very stable, in the sense of Meinshausen and Bühlmann [26], so that when we
picked 100 different subsamples from each subtype, the same edges were detected in each
of the cancer groups, and in the normal group the same network was detected 99 times.
The mixture model for the normalized correlation coefficients fits all five very well, with
rMSE=0.01. For example, Figure S5 in the Supplementary Material shows the fitted curve
for the Basal group.
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We now consider two characteristics of nodes, namely the degree, dm, and the clustering
coefficient, γm, where m indicates a node m. Let Nm = {n | Amn = 1} be the set of nodes
adjacent to node m, and let E(Nm) be the set of edges between nodes in Nm. Then
dm = |Nm| and γm = |E(Nm)|
dm(dm − 1)/2 .
If dm ≤ 1, the clustering coefficient is defined as γm = 0. By definition, γm ∈ [0, 1]. The
degree of a node is interpreted as the involvement of the node in the network and the
clustering coefficient as the connectivity among neighbors of the node. Note that γmdm
is, by definition, proportional to |E(Nm)|/(dm − 1), so it is interpreted as (approximately)
the average degree among the neighbors of node m. Note also that γmdm is bounded by
dm. To visualize and compare the properties of the networks, we plot γmdm versus dm. For
example, Figure 5 depicts the relationship between the degree and the clustering coefficients
of nodes for (a) the Normal group and (b) the Her2 group. Similar plots for the other three
subtypes are provided in the Supplementary Material. In all five groups we observe that as
the degree of a node increases, the average degree of each of its neighbors increases. The
plot for the Her2 group has a striking pattern, with three distinct ‘arms’, one of which
exhibits a very high degree of connectivity between nodes (as shown by the high values of
γmdm.) This suggests that there is at one cluster which is nearly a complete subgraph in
which each node is connected to all or most other nodes in that cluster. The presence of
such clusters is also depicted in Figure 6, which shows a bitmap of the data (restricted to
genes with at least 20 neighbors), where a black dot represents an edge between a pair of
nodes and white dots represent pairs which are not connected. To detect clusters and to
generate plots such as Figure 6, where clusters are arranged by their size, we first define the
dissimilarity between two neighboring nodes, m and n, as the number of neighbors of m
which are not neighbors of n, plus the number of neighbors of n which are not neighbors of
m. Then, we create clusters recursively as follows. In each iteration, i, we find the node, xi,
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with the largest degree and identify all of its neighbors. We sort its neighbors in increasing
dissimilarity order. So, within the i-th cluster, the nodes are arranged from closest to xi to
the farthest. Then, in the subsequent iterations node xi and all its neighbors are excluded,
until we have exhausted all the nodes.
Figure 6 shows that the genes in the second largest cluster in the Her2 network appear
to be highly connected. Figure 7 shows again the plot of γmdm versus dm, but this time,
genes identified as belonging to the second largest cluster appear in red. Clearly, the upper
‘arm’ in the plot consists of genes from that cluster.
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Figure 5: Plot of γmdm versus dm, where γm is the clustering coefficient and dm is the
degree of node m.
Next, we characterize each subtype by pathways enriched in its gene clusters. For
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Figure 6: A bitmap of the Her2 network, including only genes with at least 20 neighbors.
A black dot represents an edge between a pair of nodes, and white dots represent pairs
which are not connected. The genes were ordered according to their degree, within each
cluster.
each subtype, we perform gene set enrichment analysis [21] and find the KEGG pathways
significantly enriched in every identified cluster (p-value ≤ 0.01). We then identify uniquely
enriched pathways for each subtype compared to other subtypes (see Table 1).
Our results obtained from the pathway analysis are consistent with the previous find-
ings. The HER2 group has three uniquely enriched pathways: drug metabolism–cytochrome
P450, steroid hormone biosynthesis, and tryptophan metabolism. The relationship of drug
metabolism–cytochrome P450 to HER2 has been reported in Towles et al. [42], the rela-
tionship of steroid hormone biosynthesis to HER2 has been reported in Huszno et al. [43],
and the relationship of tryptophan metabolism to HER2 has been reported in Fisher et al.
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Figure 7: Plot of γmdm versus dm for the Her2 group. Points in red correspond to genes
identified as belonging to the second largest cluster.
[44] and Miolo et al. [45]. The basal group has two uniquely enriched pathway that are
related to genetic information processing for RNA translation: mRNA surveillance pathway
and RNA transport. The luminal A group has one uniquely enriched pathway: Bacterial
invasion of epithelial cells. The luminal B group has six uniquely enriched pathways: Base
excision repair, Dilated cardiomyopathy, Hypertrophic cardiomyopathy (HCM), Nucleotide
excision repair, Regulation of autophagy, and Tight junction. Among those, regulation of
autophagy [46], base excision repair, and nucleotide excision repair [47] are associated with
endocrine treatment resistance in breast cancer patients characterized by the expression
of estrogen receptor alpha. The normal group is characterized by pathways related to the
immune system while those pathways are not enriched or enriched in fewer clusters in all
breast cancer subtypes. Endocytosis and lysosome that are uniquely enriched in the nor-
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Table 1: Pathways characterizing the breast cancer subtypes.
Subtype Pathway Name Pathway Size Cluster Index P-value Genes
Her2 Steroid hormone biosynthesis 42 18 0.000780 AKR1C1, AKR1C2, HSD3B1, SRD5A1, AKR1D1, UGT2B28
Tryptophan metabolism 35 18 0.002258 KYAT1, DDC, MAOA, KYNU, HAAO
Drug metabolism - cytochrome P450 54 18 0.009187 ADH1C, CYP2A6, FMO5, MAOA, UGT2B28
Basal RNA transport 126 46 0.004090 CLNS1A, RAN, RANBP2, NUP160, SUMO4
mRNA surveillance pathway 68 70 0.004276 PPP2CA, PPP2R5C, PPP2R5E, PPP2R3C
LumA Bacterial invasion of epithelial cells 65 3 0.006240 CAV1, CAV2, HCLS1, ILK, ITGA5, PIK3CD, ELMO1, ARPC1B
Lum B Tight junction 118 39 8.34E-05 ACTN2, ACTN3, MYH1, MYH2, MYL2, MYLPF
Base excision repair 31 37 0.001882 FEN1, PCNA, UNG
Dilated cardiomyopathy 83 42 0.002040 MYL2, TNNC1, TPM3, TTN
Hypertrophic cardiomyopathy (HCM) 77 42 0.002040 MYL2, TNNC1, TPM3, TTN
Regulation of autophagy 30 3 0.003573 IFNA4, IFNA10, IFNA17, IFNA21
Nucleotide excision repair 41 37 0.003760 PCNA, RFC4, RFC5
Uniquely enriched pathways in each breast cancer subtype. All identified clusters are indexed by their size. The cluster index indicates the order of the clusters. P-values are adjusted to
control the false discovery rate using Benjamini and Hochberg [37].
mal group are parts of the immune system. Furthermore, Phagosome, antigen processing
and presentation, natural killer cell mediated cytotoxicity, graft-versus-host disease, T cell
receptor signaling pathway, and primary immunodeficiency are enriched in a larger number
of clusters in the normal group than other subtypes. These pathways are also part of or
related to the immune system (see Table S1 in the Supplementary Material).
5 Discussion
We propose a new approach for detecting edges in gene networks, based on co-expression
data. We consider the entire set of genes as a network in which nodes represent genes and
weights on edges represent the correlation between expression levels of pairs of genes. We
start by modeling the normalized pairwise correlations as a mixture of three components:
a normal component with mean 0, representing the majority of pairs which are not co-
expressed, and two non-null components, modeled as log-normal distributions, for positively
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and negatively correlated pairs.
From a theoretical point of view, the so-called L2N model has the advantage that the
overlap between the null component and the non-null components around 0 is negligible.
This helps to avoid identifiability problems which are known to affect other mixture models
which rely only on normal components, such as the spike-and-slab or a three-way normal
mixture model. Furthermore, the mixture model allows us to accurately estimate the pro-
portion of spurious correlations among all pairs of genes and to derive a cutoff criterion in
order to eliminate the vast majority of the edges in the graph that correspond to uncorre-
lated genes. We also derived estimators for the probabilities of Type-I and Type-II errors,
as well as the false discovery rate associated with the cutoff criterion.
From a practical point of view, this model appears to fit co-expression data extremely
well, even when the data are not generated according to the mixture model. Our simulations
show that it outperforms other methods in terms of the power to detect edges, and that
it maintains a low false discovery rate. Estimation of the model parameters is done very
efficiently, using the EM algorithm. In typical gene expression datasets which consist of
thousands of genes and millions of putative edges, computational efficiency is critical.
Our approach does not require any assumptions about the underlying structure of the
network. We only assume that the normalized correlations follow the L2N model. This is
a very modest assumption since the Fisher z-transformed correlations are indeed (asymp-
totically) normally distributed for all the uncorrelated pairs.
Our case study yielded results that are insightful and consistent with previous findings.
In particular, for the HER2 group, we identified the pathways that are known to be asso-
ciated with this subtype. For luminal B group, we identified pathways that are associated
with endocrine treatment resistance in breast cancer with estrogen receptor alpha. All the
breast cancer subtypes are less prone to have pathways related to the immune system than
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the normal group, which is reasonable because cancer is known to weaken the immune
system.
We plan to extend this method to handle time varying networks. This will be particu-
larly useful when analyzing gene expression data from repeated measures designs. We also
plan to extend the model to applications that involve multiple platforms, such as methy-
lation and proteomics. In principle, with the appropriate normalization technique for each
platform, one can simply construct a graph with G1 + . . .+Gk nodes, where Gi is the num-
ber of ‘building blocks’ observed in each platform. However, much more work is needed to
establish the theoretical framework to define ‘co-expression’ across platforms.
Supplementary Material
See attached document for additional figures for the simulations and case study. The
edgefinder R-package is available from the first author’s website https://haim-bar.
uconn.edu/software/.
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Figure S1: The average estimate of p1, the proportion of positively correlated pairs of genes,
from 20 replications, is plotted versus θ in the two negatively correlated blocks configuration.
The horizontal black line depicts the true value of p1.
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Figure S2: The observed false discovery rate in the simulations under the L2N model
(Section 3.1), as a function of the location parameter of the log-normal distributions of the
non-null components. The green horizontal line shows the level (0.01) which we used to
control the false discovery rate. Using the notation Section 2, we determined the thresholds,
c1 and c2, that correspond to this FDR level. The boxplots show the distributions across
four network structures, with 20 replications in each configuration.
Table S1: Pathways characterizing the normal group.
Pathway Name Pathway Size Cluster Index P-value Genes
Endocytosis 181 35 0.001379 HLA-B, HLA-C, HLA-E, HLA-F, HLA-G
Lysosome 109 20 0.007482 CTSB, CTSL, MAN2B1, LGMN
Primary immunodeficiency 34 4 6.69E-08 ADA, BTK, CD3D, CD4, CD8A, CD40, IL2RG, LCK, PTPRC
14 1.81E-06 CD8B, CD79A, IL7R, ZAP70, ICOS
T cell receptor signaling pathway 103 4 1.34E-06 CD3D, CD4, CD8A, CD28, FYN, ITK, LCK, LCP2, PIK3CD, PTPN6,
PTPRC, VAV1
14 0.000249 CD247, CD8B, IFNG, ZAP70, ICOS
Graft-versus-host disease 36 4 9.07E-08 CD28, CD86, HLA-A, HLA-DMA, HLA-DMB, HLA-DPA1, HLA-DPB1,
HLA-DRA, HLA-DRB1
14 0.001665 IFNG, KLRD1, PRF1
Natural killer cell mediated cytotoxicity 119 4 3.20E-08 CD48, FCER1G, FYN, HLA-A, ITGAL, ITGB2, LCK, LCP2, SH2D1A,
PIK3CD, PRKCB, PTPN6, RAC2, TYROBP, VAV1
14 0.000336 CD247, IFNG, KLRD1, PRF1, ZAP70
35 0.002522 HLA-B, HLA-C, HLA-E, HLA-G
Antigen processing and presentation 69 35 1.61E-09 B2M, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, PSME2, TAP1
4 1.80E-07 CD4, CD8A, CD74, CTSS, HLA-A, HLA-DMA, HLA-DMB, HLA-
DPA1, HLA-DPB1, HLA-DRA, HLA-DRB1
20 0.001641 CTSB, CTSL, LGMN, IFI30
14 0.007611 CD8B, IFNG, KLRD1
Phagosome 138 4 4.67E-06 CTSS, FCGR2B, HLA-A, HLA-DMA, HLA-DMB, HLA-DPA1, HLA-
DPB1, HLA-DRA, HLA-DRB1, ITGB2, NCF4, CORO1A, CLEC7A
35 3.40E-05 HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, TAP1
20 0.000366 ATP6V1B2, CTSL, FCGR2A, FCGR3B, MSR1, NCF2
11 0.003818 C1R, COMP, ITGA5, ITGAV, THBS2, MRC2
Uniquely enriched pathways (endocytosis and lysosome) and enriched in a larger number of clusters in the normal group than other subtypes (phagosome, antigen processing and
presentation, natural killer cell mediated cytotoxicity, graft-versus-host disease, T cell receptor signaling pathway, and primary immunodeficiency). All identified clusters are indexed
by their size. The cluster index indicates the order of the clusters. Note that a pathway can be enriched in multiple clusters as we performed the enrichment analysis for each cluster.
P-values are adjusted to control the false discovery rate using Benjamini and Hochberg [37].
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Figure S3: The numbers of true positive edges given the total number of edges identified by
each method. The true matrix is obtained by applying a threshold to the true covariance
matrix. The y-axis represents the number of true positive edges and the x-axis represents
the total number of edges identified. The vertical line represents the number of true edges.
The black dotted line is a regression line with 0 intercept and slope equal to the true
sparsity, which represents the expected number of true positive edges when the edges are
identified in a random manner.
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Figure S4: The numbers of true positive edges given the total number of edges using three
scale-free network configurations (G = 200, 500, 2000, where G is the number of genes).
The adjacency matrix is used as the true matrix. The y-axis represents the number of true
positive edges and the x-axis represents the total number of edges identified. The vertical
line represents the number of true edges. The black dotted line is a regression line with
0 intercept and slope equal to the true sparsity, which represents the expected number of
true positive edges when the edges are identified in a random manner.
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Figure S5: Goodness of fit plot of L2N mixture model. The distributions of wmn =
arctanh(rmn) for the Basal group. The red curve represents the null component, the green
curves represent the nonull components, and the dashed blue line represents the fitted
mixture distribution.
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Figure S6: Plot of γmdm versus dm for the Luminal A group.
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Figure S7: Plot of γmdm versus dm for the Luminal B group.
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Figure S8: Plot of γmdm versus dm for the Basal group.
